VAM
ALT icon

Visium Asset Management’s Altimmune ALT Stock Holding History

Visium Asset Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,000
Closed -$3.4M – 350
2016
Q1 		$3.4M Hold
6,000
– – 0.06% 326
2015
Q4 		$3.42M Hold
6,000
– – 0.05% 338
2015
Q3 		$2.39M Buy
6,000
+2,000
+50% +$948K 0.03% 418
2015
Q2 		$2.16M Buy
+4,000
New +$2.02M 0.03% 410

Other funds holding ALT

PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Visium Asset Management's ALT Position: Q2 2016 in Review

Visium Asset Management sold out of Altimmune (ALT) in Q2 2016, closing a stake of 6,000 shares — an estimated $3.4M sold.

Visium Asset Management first reported a position in ALT in Q2 2015 and held it in 4 quarters. The position peaked at $3.42M in Q4 2015. 47 funds tracked by Wall St. Rank hold ALT as of Q2 2016.

  • Visium Asset Management reported no remaining Altimmune position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 6,000 Altimmune shares in Q2 2016, an estimated $3.4M.
  • Visium Asset Management first reported a position in Altimmune in Q2 2015 and held it in 4 quarters.
  • Visium Asset Management's Altimmune position peaked at $3.42M in Q4 2015.
  • 47 funds tracked by Wall St. Rank held Altimmune as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.